Is Colgate-Palmolive Stock Underperforming the Nasdaq?

Core Insights - Colgate-Palmolive Company is a global leader in oral care, personal care, home cleaning, and pet nutrition products, with a market cap of approximately $76.6 billion, indicating its strong position in the consumer staples sector [1][2] Financial Performance - The company reported Q4 revenue of about $5.2 billion, reflecting a year-over-year growth of 5.8%, with adjusted EPS rising to $0.95 from $0.91 a year earlier, surpassing Wall Street expectations [6] - Over the past 52 weeks, Colgate's stock has gained 2.9%, and year-to-date, it has risen by 20.9%, while the NASDAQ Composite has gained 22.7% over the past year but declined by 3.1% this year [4] Stock Performance - Colgate's stock reached a 52-week high of $100.18 in March 2025 and is currently down about 4.7% from that peak, but has surged by 22.1% over the past three months, contrasting with a 4% decline in the broader NASDAQ [3] - The stock is trading well above its 50-day and 200-day moving averages, indicating significant momentum [4] Market Position and Analyst Sentiment - Compared to Kimberly-Clark Corporation, which has dropped 27% over the past 52 weeks, Colgate is seen as a clear outperformer, with a consensus rating of "Moderate Buy" from 21 analysts [7] - The mean price target for Colgate's stock is $96.05, suggesting a slight upside, while the highest price target of $105 indicates a potential upside of 9.9% [7]